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Summary 
Changes in structure, cellularity, hematopoietic progenitor cell and macrophage content, and 
osteoclast activity were investigated in the hematopoietic organs of the colony-stimulating factor 
l(CSF-1)-less osteopetrotic (op/op) mouse. The data indicated that op/op mice undergo an age- 
related hematopoietic recovery and resolution of osteopetrosis, suggesting that the hematopoietic 
system has the capacity to use alternative mechanisms to compensate for the absence of an important 
multifunctional growth factor, CSF-1.  In young animals, op/op femurs were heavily infiltrated 
with bone, and marrow cellularity was significantly reduced. After 6 wk of age, there was an 
increase in  the marrow space  available  for hematopoiesis.  The femoral cavity of op/op mice 
progressively enlarged, and by 22 wk of age its appearance and marrow cellularity was comparable 
to that of controls. The percentage of op/op mononuclear phagocytes, defined by F4/80 antigen 
expression, progressively increased to normal levels by 35 wk of age. There was no difference 
in the incidence of both primitive and mononuclear phagocyte-committed, CSF-l-responsive 
progenitor cells in op/op marrow, but their femoral content was significantly reduced in young 
mice. During the period of reduced hematopoiesis in the marrow of young op/op mice, splenic 
hematopoietic activity was devated. This mutant mouse represents a system for the study of 
the CSF-l-independent regulatory mechanisms involved in hematopoietic regulation. 
C 
SF-1 stimulates the survival, proliferation, and differen- 
tiation of mononuclear phagocytes and their precursors 
(1-3). Osteopetrotic (op/op) mice are characterized by an an- 
tosomal recessive inactivating mutation in the CSF-1  gene 
resulting in the absence of CSF-1  (4-7). As a consequence, 
young op/op mice have impaired mononuclear phagocyte de- 
velopment (1, 2) characterized by a deficiency of  both macro- 
phages and osteodasts.  Bone density is increased, marrow 
cavities are occluded (8-11),  and it has been reported that 
marrow cellularity of op/op mice is 10%, and marrow mac- 
rophage content is  1%,  that of control mice (12). 
Previous studies have generally been restricted to analysis 
of young op/op mice (6,  7, 9,  12,  13).  In these mice, bone 
matrix formation is elevated, but by 6 wk of age there is 
evidence of remodeling in the long bones (8, 10). This raises 
the possibility that in older op/op mice there are significant 
changes in the organization and regulation of hematopoiesis 
associated with a substantial correction of the osteopetrosis. 
In  the  present  study,  hematopoietic  and  mononuclear 
phagocyte development was investigated in op/op mice from 
2 wk to 5 mo of age. Progressive changes in the structure 
of the femoral marrow space were accompanied by a nor- 
malization of marrow cellularity and macrophage content, 
demonstrating that as op/op mice age they correct hemato- 
poietic deficiencies  in the absence of CSF-1. 
Materials and Methods 
Mice.  Mice ofop/op and wild-type control (+/+, op/+ ) geno- 
types were raised as previously described (14). Osteopetrotic (op/op) 
mice were distinguished from normal siblings  at  10 d of age by 
the absence incisor eruption,  and separated from wild-type mice 
at  weaning.  They were  fed a  pureed  mixture of mouse  food 
(Barastoc, St. Arnaud, Victoria, Australia) and infant formula (En- 
sure; Ross Laboratories, Columbus, OH) twice daily to optimize 
their nutritional  status. Control mice received mouse chow ad 
libitum. 
Growth Factors.  Human rCSF-1 (8  x  107 U/rag protein) was 
a gift from Chiron Corp. (EmeryviUe, CA). Human rIL-lc~ (2.5 
x  109 U/rag protein) was a gift from Hoffman-La Roche Inc. 
(Nutley, NJ). rlL-3 was prepared as conditioned medium from the 
genetically altered mouse mammary cell line (C127) expressing 
mouse cDNA (15). Factors  were used at optimal concentrations (16). 
Preparation  of Microscopic  Sections.  Anesthetized (Penthrane; Ab- 
bott Laboratories, North Chicago, IL) mice were perfused with 
4 ml of 2.5%  ghtaraldehyde at 0.3 ml/min into the descending 
aorta (17). Femurs were immersion fixed for a further 3 h before 
decalcification  in 10% EDTA (pH 7.0) for 5-7 d. Postfixation with 
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7.4) for 1 h was followed by dehydration in graded ethanol, and 
100% acetone for 45 min at each step in a vacuum. Femurs were 
placed in a 1:1 mixture of Spurr's resin and 100% acetone in a 
vacuum overnight, then for 6 h in fresh solution. The femurs were 
embedded in 100% Spurr's resin in a vacuum for 3 h followed by 
incubation at 60~  overnight. For light microscopy,  0.5 #m trans- 
verse sections  were cut and stained with methylene blue. For EM, 
0.9-nm sections  were cut and stained using uranyl acetate and lead 
citrate. 
Cells Suspensions.  Marrow from control  mice was collected  by 
flushing femoral shafts with cold Hepes-bui[ered balanced salt 
solution (BSS) supplemented with 2%  newborn bovine serum 
(NBBS). Femurs from op/op mice were routinely ground using a 
mortar and pestle because <20% of marrow cells could be recov- 
ered by flushing alone. The suspension  was gently vortexed to free 
ceUs adhering to bone fragments, and the supematant decanted 
and pooled, together with three washings of the bone fragments. 
Spleen cell suspensions were prepared by mincing in BSS sup- 
plemented with 2% NBBS, and dispersed through a mesh sieve. 
Cell counts were performed using a hemocytometer. 
Hematot,  oietic Progenitor  CelIAssa?s.  Marrow and spleen  cell sus- 
pensions were assayed  for low and high proliferative  potential  colony- 
forming cells (LPP-CFC and HPP-CFC), using a double-layer  nu- 
trient agar culture system (16). 
Flow Cytometric Analysis.  Bone marrow macrophage content 
was quantitated on the basis of F4/80 cell surface Ag expression 
(18). Ceils were  labeled with F4/80  Ab,  followed by FITC- 
conjugated goat anti-rat F(ab')z IgG (Kirkegaard  & Perry Labora- 
tories, Inc., Gaitbersburg, MD); each for 30 min at 4~  and were 
analyzed using a FACStar Plus  |  cell sorter (Becton Dickinson & 
Co., Mountain View, CA). A forward  vs. perpendicular  light scatter 
window was set to exclude  lymphocytic and granulocytic  cells that 
may be nonspecifically  labded with F4/80 Ab (19). Background 
fluorescence  (cell surface  binding of FITC-conjugated second Ab) 
was not >5%. 
Osteoclast Staining.  Mice  were anesthetized and perfused with 
2 ml of 1% glutaraldebyde  and 1% formaldehyde  into the descending 
aorta.  Femurs were  immersion  fixed at  4~  for  1  h  before 
decalcification  in 5% EDTA in cacodylate buffer at 4~  for 5 d. 
The femurs were dehydrated in graded ethanol and xylene for 90 
min at each step and embedded in paraplast. Sections  (10 #m) were 
cut and stained using tartrate-resistant ATPase histocbemistry. 
Resorption Pit Anal?sis.  Femurs  were eafised using blunt dis- 
section. After immersion  fixation  in 2.5% glutaraldehyde  overnight 
at 4~  and 8 h in a vacuum, they were placed in 4% (wt/vol) 
NaOC1 to remove remaining tissue. Femurs were dehydrated in 
graded ethanol for 125 rain in a vacuum, and, after critical point 
drying, were sputter coated with 30 ~m of gold and examined  by 
scanning electron microscopy. 
Statistical Analysis.  Differences  between means were evaluated 
by one-way analysis of variance (ANOVA). 
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Figure 1.  Age-related changes in the femoral bone marrow content of 
op/op (A) and control  (m) mice. Values  are the means + SEM of  between 
three and eight determinations  per time point. 
lularity in young op/op mice reflected occlusion of the marrow 
space by bone: there was no obvious central marrow cavity 
at 4 wk of age (Fig.  2 A). By 6 wk of age,  formation of 
a central marrow cavity resulted in an increase in the space 
available for hematopoiesis (Fig. 2, B and C). Thereafter, the 
Results 
Changes in Bone Structure, Marrow Cellularity, and Heraato- 
poietic Activity of  op/op Mice  The femoral marrow cellularity 
of control mice progressively increased postnatally, attaining 
adult levels by 6-8 wk of age. In contrast, op/op marrow cd- 
lularity remained  stable  at  ,,02.5  x  106  cells  per  femur 
during this period, and by 8 wk had only attained 16% of 
the cellularity of control femurs (Fig. 1). This decreased cd- 
Figure 2,  Age-related  changes in the op/op femoral bone marrow cavity. 
Transverse sections of the diaphyseal region. (,4) oF/oF  femur at 4 wk (x 26); 
(B) op/op femur at 6 wk (￿  (C) an enlargement orB, demonstrating 
the development of the op/op marrow cavity (￿  (D) op/op femur at 
22 wk (x28);  (E) control littermate femur at 4 wk (x26);  (F) control 
littermate femur at 22 wk (x 25). 
238  Hematopoiesis in Osteopetrotic Mice Table  1.  F4/80 Ag Expression on Marrow Mononuclear Ceils 
Percentage F4/80 § cells 
Age  op/op  Control 
w/e 
3  22.7  _+  3.2  42.4  _+  5.0 
8  35.4  _+ 6.4  54.7  _+ 3.0 
35  36.7  _+ 8.5  34.8  _+ 6.2 
Values are the mean +  SEM of analyses in three  individual mice. 
Figure 3.  Evidence of osteochst  activity in op/op femoral bone. Lon- 
gitudinal sections of femurs from 22-wk-old op/op (A,  x 126) and control 
(B,  x 131) mice. Arrows indicate ATPase-labeled  osteoclasts. Scanning elec- 
tron microffraphs of the femora1 surface from 4-wk-old op/op (C,  x377); 
4-wbold control mice (D,  x 204); 22-wk-old op/op (E, x406; G,  x 765); 
17-wk-old control mice (F,  x447; H,  x594). 
marrow cavity progressively enlarged, and by 22 wk of age 
(Fig. 2 D), its appearance was comparable to that of control 
mice (Fig. 2, E  and F). However, the femurs of op/op mice 
remained shorter and more stunted than those of control mice 
at all ages examined. 
k-  The increase in marrow space in op/op femurs was accom-  -~ 
panied by an increase in cellularity, which also became com-  IF  so 
parable  to that of control femurs by 22 wk of age (Fig.  1).  ,.~ 
This progressive increase in space available for hematopoiesis  ~  4o 
was indicative of increased osteoclast  activity.  Very few os-  ~  ~o 
teoclasts were observed along the edge of the marrow cavity  o 
in young op/op mice (data not shown), but by 22 wk of age 
these cells were easily detected along the femoral surface (Fig.  co  20 
3 A). Osteoclast activity was confirmed by examination of 
the femoral surface in young and old op/op mice using scan-  /  10 
ning electron microscopy.  Resorptive pits are indicative of 
osteoclast  activity,  but these were absent in young (4 wk)  ~  0 
op/op mice (Fig. 3 C). As well, the rugged irregular edges 
of the femoral surface were suggestive of  bone formation (Fig. 
3 C). However, by 22 wk of age, the femoral surface of  op/op 
mice resembled that of control mice, with resorptive pits being 
clearly distinguishable (Fig.  3, E-H). 
Flow cytometric analysis of F4/80 surface Ag expression 
on mononuclear cells with defined light scattering proper- 
ties (see Materials and Methods) demonstrated an age-related 
correction of the marrow macrophage deficiency observed in 
young op/op mice. At 3 wk of age the proportion of F4/80 + 
cells was '~50%  that in control marrow (Table 1). By 35 
wk of age the proportion and number of F4/80 + cells in 
the op/op mouse was comparable to that of controls (Table 
1).  The  presence  of macrophages  in  op/op  marrow  was 
confirmed  by electron microscopy. No morphological differ- 
ences were observed between macrophages detected in op/op 
and control mice at any age examined, and paracrystaUine 
inclusions (20) were present in macrophages of normal and 
op/op mice of comparable age (data  not shown). 
Changes in Heraatopoietic  Progenitor  Cell Populations  in op/op 
M/cA  The hematopoietic status of op/op mice was evaluated 
by in vitro donal assay of LPP-CFC and HPP-CFC. LPP- 
CFC are CSF-l-dependent, lineage-restricted mononudear 
phagocyte progenitors. HPP-CFC with a synergistic require- 
ment for II.-1, Ib3, and CSF-1 are closely related to primitive 
hematopoietic cells with long-term repopulating ability in 
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Figure 4.  Total femoral LPP-CFC (hatched bars) and HPP-CFC (filk,  d 
bars) content of young and old op/op mice. 
239  Begg et al.  Brief Definitive Report Table  2.  Progenitor  Cell Incidence in Spleens of op/op and 
Control Mice 
progenitor cell type could be detected in the livers of normal 
or op/op mice at any age examined (3-27 wk) (data not shown). 
CFC/2,500  cells 
Progenitor  Age  op/op  Control 
LPP 
HPP 
wk 
6  29  _+  3.6  6.8  _+  1.3 
27  6  _+  1.2  6.3  +_  1.1 
6  1.8  +_  0.4  0.1  _+  0.05 
27  0.2  +  0.1  0.1  _+  0.05 
Values are means  _+  SEM of three replicate dishes for each of three mice. 
vivo (21). There were no differences in the incidence of LPP- 
CFC or HPP-CFC in the marrow of op/op and control mice 
at any age examined (data not shown). However, the total 
femoral content of these progenitors (Fig. 4) reflected the age- 
related changes observed in marrow cellularity (Fig. 1). LPP- 
CFC and HPP-CFC levels in 6-wk-old op/op mice were ",,10- 
fold less than that of control mice. By 22 wk of age, the 
femoral progenitor cell content in op/op and control mice was 
comparable (Fig. 4). 
The diminished space for marrow hematopoiesis and the 
reduced hematopoietic activity in young op/op mice were cor- 
related with an increase in splenic hematopoiesis. At 6 wk 
of age, the spleens ofop/op mice were significantly enlarged, 
and the incidence and content of both LPP-CFC and HPP- 
CFC were significantly higher than those of control mice 
(Table 2, Fig. 5). By 27 wk of age, at a time when op/op 
marrow cellularity had normalized (Fig. 1), the incidence and 
content of progenitor cells in the spleen had declined to values 
equivalent to those in control mice (Table 3, Fig. 5). Neither 
op/op  Confrol 
7O  10 
(~)-  50  7 
4O  6 
o  ~  ~o 
.30  4 
V  f 
--.I  0  0  -I-" 
6  22  6  22 
Age  (wk) 
Figure 5.  Total splenic LPP-CFC (hatched bars) and HPP-CFC (filled bars) 
content of young and  old op/op mice. 
Discussion 
Previous studies of op/op mice, which are largely restricted 
to the biology of macrophages and osteodasts in young mice, 
indicate that occlusion of the marrow cavity by bone is as- 
sociated with a severe decrease in cellularity, and a deficiency 
of osteodasts and mononuchar phagocytes (11, 12, 22-26). 
These findings were confirmed, however, it appears that the 
decrease in marrow cellularity is less severe than pmriously 
reported, and the osteopetrosis and hematopoiesis deficien- 
cies in op/op mice are not permanent. 
In contrast to previous studies of op/op mice up to 4 mo 
of age, indicating no increase in marrow cellularity or fre- 
quency of F4/80 + cells (25, 27), the present study showed 
a progressive age-related increase in marrow cellularity and 
macrophage content. This increase in cellularity was apparent 
by 8 wk, and continued until normal levds were reached by 
22 wk. By 35 wk of age the frequency and total number 
of F4/80 + cells was also normal. 
The normalization of  marrow cellularity in op/op mice was 
associated with remodeling of the marrow cavity, reduction 
of bone matrix formation, and the appearance of resorptive 
pits on the femoral surface. During this period, there was 
a slow resolution of the osteopetrosis with the formation of 
a marrow space comparable to that seen in control mice. In 
agreement  with our data, other workers (8, 10, 26) have also 
noted evidence of the beginnings of the formation of a fem- 
oral shaft in 6-wk-old op/op mice. 
Variations in the data from different laboratories appear 
to be due to differences in bone sampling methodology and 
nutritional status of the mice. As to the latter, we have no- 
ticed that the combination of an enriched diet and early sepa- 
ration of op/op mice from their normal littermates  greatly 
improves the rate of hematopoietic recovery. 
Although there were comparable proportions of HPP-CFC 
and LPP-CFC in the marrow of  young op/op and control mice, 
the absolute number of these progenitors was reduced. The 
normal frequency of LPP-CFC in op/op marrow from young 
mice was unexpected,  since in vitro it has been shown that 
generation of LPP-CFC from HPP-CFC is CSF-1 dependent 
(16, 28). In op/op mice it is possible that both the rate of 
generation of LPP-CFC as well as their CSF-l-induced differen- 
tiation are slowed, resulting in the same concentration of LPP- 
CFC as in normal mice. Alternatively, the normal concen- 
tration of  LPP-CFC (and HPP-CFC) could be due to the pres- 
ence of a growth factor with a CSF-l-like effect. 
Interestingly, during the period of suppressed marrow he- 
matopoiesis in young op/op mice, there was an increase in 
splenic hematopoiesis and cellularity. Splenic granulocytopoi- 
esis and megakaryocytopoiesis was elevated (data not shown), 
as  well as  the frequency and  number of LPP-CFC  and 
HPP-CFC. 
Other studies have indicated that daily administration  of 
CSF-1 to  newborn op/op mice is  required  to  prevent  os- 
teopetrosis and accompanying hematopoietic defidencies (29). 
240  Hematopoiesis  in Osteopetrotic Mice However, our data suggest that the hematopoietic system has 
the capacity to use alternative mechanisms to compensate for 
the absence of CSF-1 in op/op mice. Two growth factors that 
may be involved, GM-CSF and IL-3, are normal or devated 
in op/op mice (6).  However, administration of GM-CSF to 
young op/op mice does not resolve osteopetrosis (30). Inves- 
tigations of possible compensatory mechanisms in op/op mice 
should contribute to our understanding of hematopoietic regu- 
lation and bone remodeling. 
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